JohnEdwinTrusheimMD

Neurology • Minneapolis, MN

Sleep Medicine, Neurooncology

Physician

Join to view full profile

Dr. Trusheim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Trusheim's full profile

Already have an account?

Office
800 E 28th St
Minneapolis, MN 55407
Phone+1 612-863-3732

Fax+1 763-287-2310
Is this information wrong?

Education & Training

University of MinnesotaResidency, Neurology, 1983 - 1986
University of Missouri-ColumbiaResidency, Internal Medicine, 1980 - 1983
University of Missouri-Columbia School of MedicineClass of 1980

Certifications & Licensure

MN State Medical License 1986 - 2025
WI State Medical License 1986 - 1993
IA State Medical License 1987 - 1992
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Sleep Medicine

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2011-2012

Clinical Trials

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer Start of enrollment: 2006 Dec 01
Active, not recruiting
Phase 3
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
Completed
Phase 2
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors Start of enrollment: 2014 Mar 01
Completed
Phase 1, Phase 2
Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms Start of enrollment: 2018 Mar 15
Completed
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma Start of enrollment: 2019 Jul 30
Recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

169 citations
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
Liau, L. M., Ashkan, K., Tran, D. D., Campian, J. L., Trusheim, J. E., Cobbs, C. S., Heth, J. A., Salacz, M., Taylor, S., D'Andre, S. D., Iwamoto, F. M., Dropcho, E. J...> ;Journal of translational medicine. 2018 May 31
5 citations
Carboplatin-associated Cranial Neuropathy.
Shanlee M. Stevens, Collin M. McClelland, John E. Trusheim, Michael S. Lee> ;Neuro-Ophthalmology. 2018 Jan 26
29 citations
A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma.
John E. Trusheim, Erin Dunbar, James Battiste, Fabio M. Iwamoto, Nimish Mohile, Denise Damek, Daniela A. Bota, Jennifer Connelly> ;CNS Oncology. 2017 Jan 1

Press Mentions

Listening to Patients: Living with Terminal CancerJanuary 16th, 2019
CNS Oncology Publishes Tumor Treating Fields Treatment Planning and Patient Follow-up Guidelines in GlioblastomaSeptember 19th, 2016

Professional Memberships

American Academy of Neurology - AAN
Member

Hospital Affiliations

M Health Fairview University of Minnesota Medical CenterMinneapolis, Minnesota
Abbott Northwestern HospitalMinneapolis, Minnesota
M Health Fairview Southdale HospitalMinneapolis, Minnesota
St. Cloud VA Medical CenterSaint Cloud, Minnesota